ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
TM
Tianjin Medical University Cancer Institute and Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Tianjin Medical University Cancer Institute and Hospital takes part in 11 sessions at ESMO 2026 in Madrid. Its work covers treatment research across lung, breast and digestive cancers. It includes studies of drug combinations and radiotherapy before surgery, including approaches for pancreatic and lung cancers.
| Organization | ESMO 2026 Attendance |
|---|---|
TM Tianjin Medical University Cancer Institute and Hospital Tianjin, China | |
Cancer hospital and research institute in Tianjin, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Early CA19-9 control after irreversible electroporation in advanced pancreatic ductal adenocarcinoma Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Patient and oncologist preferences regarding CDK4/6 inhibitor adjuvant therapy for HR+/HER2- early breast cancer in China Breast cancerNursing & supportive care Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Long-term results from the phase 1 study of HRS-7058, a KRAS G12C inhibitor (G12Ci), in advanced solid tumors with KRAS G12C mutation Gastrointestinal cancersLung & thoracic cancers Poster Sat Oct 24 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Tianjin Medical University Cancer Institute and Hospital
Tell us what you sell and we’ll find the people at Tianjin Medical University Cancer Institute and Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction